Rigel Pharmaceuticals, Inc. logo RIGL - Rigel Pharmaceuticals, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 8
HOLD 7
SELL 0
STRONG
SELL
0
| PRICE TARGET: $27.33 DETAILS
HIGH: $42.00
LOW: $2.00
MEDIAN: $38.00
CONSENSUS: $27.33
DOWNSIDE: 5.79%
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999
Revenue
Revenue 294.3 179.3 116.9 120.2 149.2 108.6 59.3 44.5 4.5 20.4 28.9 8.2 7.2 2.2 4.8 125 0.8 0 12.6 33.5 16.5 4.7 11.1 15.8 15.3 13.2 9.0
Cost of Revenue 19.6 18.6 7.1 1.7 1.1 0.9 0.9 0.3 46.3 63.4 62.8 67.7 75.3 78.8 0 0 1.4 1.4 0 0 1.1 0 0 0 0 (7.6) (1.9)
Gross Profit 274.7 160.6 109.8 118.5 148.2 107.7 58.4 44.2 (41.8) (43.1) (33.9) (59.4) (68.2) (76.5) 4.8 125 0.8 0 12.6 33.5 16.5 4.7 11.1 15.8 15.3 20.8 10.9
Operating Expenses
R&D Expenses 33.3 23.4 24.5 60.3 65.2 60.1 52.9 46.9 46.3 63.4 62.8 67.7 75.3 78.8 69.3 64.4 90.7 109.7 70.4 57.0 52.0 48.5 43.4 43.4 32.3 32.0 17.1
SG&A Expenses 115.9 113.1 105.7 112.5 91.9 76.6 74.6 70.0 37.8 20.9 17.8 31.8 19.6 22.8 21.8 25.3 20.9 27.0 21.8 19.6 12.4 13.1 8.5 9.5 8.0 6.7 4.0
Other Expenses 0 0 0 1.3 3.5 0 0 0 0 5.8 0 (9.3) 1.7 0 0 0 0 0 0 0 0 0 0 0 0 7.6 1.9
Operating Expenses 149.2 136.4 130.3 174.0 160.6 136.7 127.5 116.9 84.1 90.1 80.6 99.5 96.6 101.6 91.1 89.7 111.6 135.3 92.1 76.5 63.3 61.6 51.9 52.8 40.3 46.3 23.0
Operating Income
Operating Income 125.5 24.2 (20.5) (55.5) (12.5) (29.0) (69.1) (72.7) (79.6) (69.7) (51.7) (91.2) (89.5) (99.4) (86.4) 35.3 (112.0) (136.7) (79.5) (43.0) (47.9) (56.9) (40.8) (37.0) (25.0) (25.5) (12.1)
Interest Expense 7.3 7.9 6.9 3.7 4.9 1.4 0.3 0 0 0 0 0 0.0 0.0 0.0 0.1 0.2 0.2 0.2 0.3 0.3 0.3 0.6 0.9 0.8 0.9 0
Interest Income 3.7 2.1 2.3 0.7 0.0 0.6 2.5 2.2 0.9 0.4 0.2 0.2 0.4 0.5 0.4 0.3 0.6 4.4 5.5 5.7 2.9 1.0 0.4 0.9 2.0 1.1 0
Profitability
EBITDA 131.6 28.5 (17.0) (53.9) (11.3) (27.7) (65.9) (69.9) (77.5) (63.0) (50.3) (88.9) (85.2) (96.9) (84.0) 39.3 (110.0) (130.8) (79.5) (41.6) (46.7) (54.5) (37.6) (31.2) (18.2) (17.9) (10.2)
EBIT 129.1 26.3 (18.2) (54.9) (12.4) (28.4) (66.6) (70.5) (78.0) (64.0) (51.7) (91.2) (87.8) (99.4) (85.9) 38.0 (111.4) (132.3) (79.5) (43.0) (47.9) (56.9) (40.8) (37.0) (25.0) (25.5) (12.1)
Income Before Tax 121.8 18.4 (25.1) (58.6) (17.3) (29.7) (66.9) (70.5) (78.0) (69.2) (51.5) (90.9) (89.0) (98.8) (86.0) 37.9 (111.6) (132.4) (74.3) (37.6) (45.3) (56.3) (41.2) (37.0) (23.8) (25.4) 0
Income Tax Expense (245.2) 0.9 0 0 0.6 0 0 0 0 0 0 0 0 0 0.4 0.1 (0.1) (0.1) 0 0 0 0 0.4 0 0 0 0.3
Net Income 367.0 17.5 (25.1) (58.6) (17.9) (29.7) (66.5) (70.5) (78.0) (69.2) (51.5) (90.9) (89.0) (98.8) (86.0) 37.9 (111.5) (132.3) (74.3) (37.6) (45.3) (56.3) (41.2) (37.0) (23.8) (25.4) (12.4)
Per Share Data
EPS (Basic) 20.40 0.99 -1.44 -3.40 -1.10 -1.80 -4.00 -4.40 -6.17 -7.33 -5.82 -10.37 -10.20 -2.46 -3.67 1.62 -2.73 -3.67 -2.57 -1.51 -2.07 -3.12 -3.62 -7.31 -5.75 -31.43 -355.49
EPS (Diluted) 19.48 0.99 -1.44 -3.40 -1.10 -1.80 -4.00 -4.40 -6.17 -7.33 -5.82 -10.37 -10.20 -6.14 -3.67 0.72 -2.73 -3.67 -2.57 -1.51 -2.07 -3.12 -3.62 -7.30 -5.75 -31.43 -355.49
Shares Outstanding 18.0 17.6 17.4 17.2 17.0 16.9 16.7 16.1 12.6 9.4 8.8 8.8 8.7 40.1 23.4 23.4 40.9 36.0 28.9 24.9 21.9 18.1 11.4 5.1 4.1 0.8 0.0
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2009 2008 2004 2003 2002 2001 2000 1999
Current Assets
Cash & Cash Equivalents 40.6 56.7 32.8 24.5 18.9 30.4 22.5 76.3 38.3 17.6 14.7 46.0 10.5 9.6 26.5 11.5 49.0 5.8
Short-Term Investments 114.4 20.6 24.1 33.7 106.1 27.0 75.6 52.2 77.5 57.1 118.6 88.5 60.9 36.9 0.8 21.9 4.0 0
Net Receivables 51.8 41.6 30.6 40.3 15.5 16.0 10.1 4.1 0 0 0 0 0.7 1.3 7.7 1.2 0.7 2.3
Inventory 11.5 6.0 5.5 9.1 6.6 1.6 1.4 0.9 0 0 0 0 0 0 0 0 0 0
Other Current Assets 21.9 10.2 6.3 8.3 0 0 0 3.5 1.7 1.4 0 3.6 0 0 0 0 1.0 0.3
Total Current Assets 240.2 135.1 99.3 115.9 154.5 89.0 119.0 137.0 117.4 76.2 136.0 138.1 74.2 50.1 36.9 36.5 54.7 8.5
Non-Current Assets
Property, Plant & Equipment 0.9 0.3 1.0 2.8 11.9 20.6 27.9 1.4 0.9 1.2 2.3 3.6 2.8 3.5 5.2 8.4 9.3 8.4
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Intangible Assets 24.7 27.1 13.9 14.9 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long-Term Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Assets 1.9 1.4 3.1 0.6 1.0 0.8 0.7 0.7 0.8 0.8 2.5 2.2 1.8 1.9 2.3 1.5 0.2 0.2
Total Non-Current Assets 273.4 28.9 18.0 18.4 12.9 21.4 28.6 2.1 1.7 1.9 4.8 5.8 4.6 5.4 7.5 9.9 9.6 8.6
Total Assets 513.6 164.0 117.2 134.3 167.3 110.4 147.6 139.1 119.1 78.1 140.7 143.9 78.8 55.5 44.3 46.4 64.3 17.2
Current Liabilities
Account Payables 7.2 3.3 7.1 22.5 3.8 3.7 4.2 6.4 2.6 5.6 3.2 6.0 1.9 1.4 3.5 2.0 1.3 0.9
Short-Term Debt 30.4 7.3 7.2 0 0 0 0 0 0 0 0 1.3 1.3 2.3 3.4 3.2 3.0 2.2
Deferred Revenue 0 27.8 17.0 13.5 10.5 3.0 25.3 1.0 (0.3) (3.2) (1.1) 3.2 3.7 2.2 4.1 3.3 2.4 0
Other Current Liabilities 61.6 10.1 12.3 13.9 24.2 9.6 8.8 10.4 0.3 6.0 0 13.9 1.2 0 0 0 1.4 6.5
Total Current Liabilities 99.2 63.3 53.3 65.2 63.6 40.8 58.2 27.7 18.3 22.6 17.8 24.2 11.4 8.1 14.4 10.2 8.1 9.5
Non-Current Liabilities
Long-Term Debt 22.9 52.4 52.4 39.4 19.9 19.8 9.8 0 0 0 0 2.1 0 0 0 4.2 6.2 5.5
Deferred Tax Liabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 (0.5) (2.1) (2.2) (0.4) 0
Other Non-Current Liabilities 0 45.0 39.9 42.3 52.7 5.0 5.1 0.1 0.1 0.5 0.2 11.4 14.3 6.3 2.2 (1.1) 1.0 1.4
Total Non-Current Liabilities 22.9 97.4 92.6 82.7 73.4 35.5 35.5 1.5 0.1 0.5 13.1 15.5 15.1 7.5 4.5 7.3 7.2 6.9
Total Liabilities 122.1 160.7 145.9 147.9 137.0 76.4 93.8 29.2 18.5 23.1 30.9 39.7 26.5 15.6 18.9 17.5 15.3 16.4
Stockholders' Equity
Common Stock 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Retained Earnings (1,023.0) (1,390.1) (1,407.5) (1,382.5) (1,323.9) (1,306.0) (1,276.2) (1,209.3) (1,138.9) (1,060.9) (613.3) (501.8) (212.3) (156.0) (114.8) (77.8) (54.0) (28.6)
Accumulated Other Comprehensive Income 0.2 0.0 0.0 (0.2) (0.1) (0.0) 0.0 (0.0) (0.1) (0.0) (0.0) 0.4 (0.3) (0.2) (0.8) (2.4) (5.8) (5.8)
Total Stockholders' Equity 391.5 3.3 (28.6) (13.6) 30.4 34.0 53.8 109.9 100.6 55.0 109.9 104.2 52.3 40.0 25.4 28.9 49.0 0.8
Total Liabilities & Equity 513.6 164.0 117.2 134.3 167.3 110.4 147.6 139.1 119.1 78.1 140.7 143.9 78.8 55.5 44.3 46.4 64.3 17.2
Debt Metrics
Total Debt 53.3 60.0 60.6 41.6 30.6 39.1 36.3 0 0.3 3.5 1.9 3.4 2.1 3.5 5.7 7.4 9.1 7.7
Net Debt 12.7 3.2 27.8 17.1 11.7 8.7 13.8 (76.3) (38.0) (14.2) (12.8) (42.6) (8.4) (6.1) (20.8) (4.1) (39.9) 1.8
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2005 2004 2003 2002 2001 2000 1999
Operating Activities
Net Income 367.0 17.5 (25.1) (58.6) (17.9) (29.7) (66.9) (70.5) (78.0) (69.2) (45.3) (56.3) (41.2) (37.0) (23.8) (25.4) (12.4)
Depreciation & Amortization 2.4 2.2 1.2 1.0 1.2 0.7 0.7 0.6 0.5 0.9 1.2 2.4 3.2 5.8 6.8 7.6 1.9
Stock-Based Compensation 12.7 12.4 8.8 12.4 9.5 7.3 9.1 7.7 6.0 7.3 0.0 0.1 0.5 1.0 2.6 4.9 0
Change in Working Capital (19.5) 0.2 9.5 (29.0) 9.7 (30.3) 16.7 4.1 (5.4) (15.8) 11.0 13.3 4.7 (3.1) 1.6 (1.2) 0.9
Other Non-Cash Items (41.1) (0.8) (0.2) 0.5 3.4 (0.1) (1.1) (0.8) 0.5 0.8 (2.1) 2.5 0.9 (0.2) (0.5) 5.3 1.7
Operating Cash Flow 75.7 31.5 (5.7) (73.8) 5.9 (52.2) (41.5) (58.8) (77.6) (75.9) (35.2) (38.2) (32.4) (34.5) (16.0) (11.6) (7.8)
Investing Activities
Capital Expenditure 0 (0.4) (15) (0.5) (0.6) (1.3) (1.5) (1.1) (0.2) (0.8) (1.8) (1.5) (1.2) (1.6) (3.2) (3.6) (7.1)
Acquisitions 0 0 0 0 0 0 0 1.1 0.7 0.1 0 0 0 (25.0) 0 0 0
Purchases of Investments (153.5) (35.3) (31.2) (28.9) (141.5) (81.7) (145.3) (78.0) (116.9) (103.1) (89.6) (96.4) (42.1) (26.7) (47.5) (4.0) 0
Sales/Maturities of Investments 61.1 39.7 41.6 101.2 62.0 130.4 123.1 104.1 96.8 128.7 89.2 72.2 6 47.8 29.6 0 0
Other Investing Activities 0 0.1 0.3 0.9 0 0 0 (1.1) 0.7 0.1 0 0 0.1 25.0 0 0 0
Investing Cash Flow (92.4) 4.1 (4.3) 72.8 (80.0) 47.5 (23.7) 25.0 (19.5) 24.9 (2.2) (25.8) (37.3) 19.5 (21.1) (7.6) (7.1)
Financing Activities
Net Debt Issuance (7.5) 0 19.9 19.5 0 10.0 9.8 0 0 0 0.1 (1.4) (2.2) (1.7) (1.3) 1.1 5.3
Stock Repurchased 0 (10) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 0 (1.6) (1.6) (13.0) 62.7 2.6 1.6 4.7 3.5 1.6 0 0 0.4 0 0 0 0
Financing Cash Flow 0.6 (11.6) 18.4 6.5 62.7 12.6 11.4 71.9 117.7 25.2 103.6 64.8 52.8 30.1 (0.4) 62.4 11.3
Cash Position
Net Change in Cash (16.1) 24.0 8.3 5.6 (11.5) 7.9 (53.8) 38.0 20.7 (25.8) 66.3 0.9 (16.9) 15.0 (37.5) 43.2 (3.7)
Cash at Beginning 56.7 32.8 24.5 18.9 30.4 22.5 76.3 38.3 17.6 43.5 10.5 9.6 26.5 11.5 49.0 5.8 9.5
Cash at End 40.6 56.7 32.8 24.5 18.9 30.4 22.5 76.3 38.3 17.6 76.8 10.5 9.6 26.5 11.5 49.0 5.8
Free Cash Flow 75.7 31.1 (20.7) (74.2) 5.3 (53.4) (43.0) (59.9) (77.7) (76.7) (37.0) (39.7) (33.7) (36.2) (19.2) (15.2) (14.9)
Key Metrics 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999
Income Statement
Revenue 294.3 179.3 116.9 120.2 149.2 108.6 59.3 44.5 4.5 20.4 28.9 8.2 7.2 2.2 4.8 125 0.8 0 12.6 33.5 16.5 4.7 11.1 15.8 15.3 13.2 9.0
Gross Profit 274.7 160.6 109.8 118.5 148.2 107.7 58.4 44.2 (41.8) (43.1) (33.9) (59.4) (68.2) (76.5) 4.8 125 0.8 0 12.6 33.5 16.5 4.7 11.1 15.8 15.3 20.8 10.9
Operating Income 125.5 24.2 (20.5) (55.5) (12.5) (29.0) (69.1) (72.7) (79.6) (69.7) (51.7) (91.2) (89.5) (99.4) (86.4) 35.3 (112.0) (136.7) (79.5) (43.0) (47.9) (56.9) (40.8) (37.0) (25.0) (25.5) (12.1)
Net Income 367.0 17.5 (25.1) (58.6) (17.9) (29.7) (66.5) (70.5) (78.0) (69.2) (51.5) (90.9) (89.0) (98.8) (86.0) 37.9 (111.5) (132.3) (74.3) (37.6) (45.3) (56.3) (41.2) (37.0) (23.8) (25.4) (12.4)
EPS (Diluted) 19.48 0.99 -1.44 -3.40 -1.10 -1.80 -4.00 -4.40 -6.17 -7.33 -5.82 -10.37 -10.20 -6.14 -3.67 0.72 -2.73 -3.67 -2.57 -1.51 -2.07 -3.12 -3.62 -7.30 -5.75 -31.43 -355.49
Balance Sheet
Cash & Equivalents 40.6 56.7 32.8 24.5 18.9 30.4 22.5 76.3 38.3 17.6 14.7 46.0 10.5 9.6 26.5 11.5 49.0 5.8
Total Assets 513.6 164.0 117.2 134.3 167.3 110.4 147.6 139.1 119.1 78.1 140.7 143.9 78.8 55.5 44.3 46.4 64.3 17.2
Total Debt 53.3 60.0 60.6 41.6 30.6 39.1 36.3 0 0.3 3.5 1.9 3.4 2.1 3.5 5.7 7.4 9.1 7.7
Stockholders' Equity 391.5 3.3 (28.6) (13.6) 30.4 34.0 53.8 109.9 100.6 55.0 109.9 104.2 52.3 40.0 25.4 28.9 49.0 0.8
Cash Flow
Operating Cash Flow 75.7 31.5 (5.7) (73.8) 5.9 (52.2) (41.5) (58.8) (77.6) (75.9) (35.2) (38.2) (32.4) (34.5) (16.0) (11.6) (7.8)
Capital Expenditure 0 (0.4) (15) (0.5) (0.6) (1.3) (1.5) (1.1) (0.2) (0.8) (1.8) (1.5) (1.2) (1.6) (3.2) (3.6) (7.1)
Free Cash Flow 75.7 31.1 (20.7) (74.2) 5.3 (53.4) (43.0) (59.9) (77.7) (76.7) (37.0) (39.7) (33.7) (36.2) (19.2) (15.2) (14.9)